Danaher Co. (NYSE:DHR) Shares Sold by State of Alaska Department of Revenue

State of Alaska Department of Revenue cut its holdings in shares of Danaher Co. (NYSE:DHR) by 2.7% during the fourth quarter, HoldingsChannel.com reports. The fund owned 73,287 shares of the conglomerate’s stock after selling 2,010 shares during the period. State of Alaska Department of Revenue’s holdings in Danaher were worth $16,823,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Heck Capital Advisors LLC acquired a new position in shares of Danaher during the 4th quarter worth approximately $27,000. Decker Retirement Planning Inc. purchased a new position in Danaher during the fourth quarter worth approximately $31,000. Teachers Insurance & Annuity Association of America acquired a new position in Danaher during the third quarter worth $39,000. MidAtlantic Capital Management Inc. purchased a new stake in Danaher in the 3rd quarter valued at $40,000. Finally, FSA Wealth Management LLC acquired a new stake in shares of Danaher in the 3rd quarter worth $50,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Activity at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 10.90% of the company’s stock.

Danaher Stock Performance

Shares of DHR stock opened at $211.92 on Thursday. The company has a market cap of $153.07 billion, a P/E ratio of 40.14, a PEG ratio of 2.80 and a beta of 0.83. The firm has a fifty day moving average price of $234.50 and a 200 day moving average price of $252.68. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. Danaher Co. has a 12 month low of $210.04 and a 12 month high of $281.70.

Danaher (NYSE:DHR) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the company posted $2.09 EPS. Sell-side analysts predict that Danaher Co. will post 7.77 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were given a dividend of $0.27 per share. The ex-dividend date was Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.51%. Danaher’s dividend payout ratio is presently 20.45%.

Analysts Set New Price Targets

A number of brokerages have commented on DHR. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price on the stock in a research note on Friday, December 13th. Wells Fargo & Company cut their target price on Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Barclays reduced their price objective on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. UBS Group dropped their price target on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. Finally, Stephens reaffirmed an “overweight” rating and set a $315.00 price objective on shares of Danaher in a research report on Wednesday, October 23rd. Seven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average price target of $278.00.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.